NYU Langone Health: Experimental Drug Blocks COVID-19 Viral Entry Into Lung Cells
September 19, 2020
September 19, 2020
NEW YORK, Sept. 19 (TNSRes) -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
An experimental compound prevents the virus that causes 2019 coronavirus disease (COVID-19) from entering human airway cells, a new study finds.
Posted online recently on the preprint server bioRxiv, the work revolves around the structure of SARS-CoV-2, the virus causing the current pandemic. This virus has on its surface . . .
An experimental compound prevents the virus that causes 2019 coronavirus disease (COVID-19) from entering human airway cells, a new study finds.
Posted online recently on the preprint server bioRxiv, the work revolves around the structure of SARS-CoV-2, the virus causing the current pandemic. This virus has on its surface . . .